Evidence map›Paper›PMID 37728667›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2024

[

Rong Lin, Chao Wang, Shaohao Chen, Tingting Lin, Hai Cai, Shaoming Chen, Yun Yang, Jiaying Zhang, Fuqi Xu, Jingjing Zhang and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. [European journal of nuclear medicine and molecular imaging · 2025
    Trial
  3. Comparative study of [Theranostics · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Rong Lin *Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
Chao Wang *Department of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
Shaohao ChenDepartment of Urology, Urology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Tingting LinDepartment of Urology, Urology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Hai CaiDepartment of Urology, Urology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, China.
Shaoming ChenDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
Yun YangDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
Jiaying ZhangDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
Fuqi XuDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China.
Jingjing ZhangDepartments of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. j.zhang@nus.edu.sg.
Xiaoyuan ChenDepartments of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119074, Singapore. chen.shawn@nus.edu.sg.
Jie ZangDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China. 15901495106@163.com.
Weibing MiaoDepartment of Nuclear Medicine, the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350005, Fujian Province, China. miaoweibing@126.com.
First Affiliated Hospital of Fujian Medical University · CNFujian Medical University · CNNational University of Singapore · SG

Funding

Fujian Provincial Health Technology Project 2021QNA031Joint Funds for the Innovation of Science and Technology, Fujian Province 2021Y9094Joint Funds for the Innovation of Science and Technology, Fujian Province 2021Y9134Natural Science Foundation of Fujian Province 2022J01694Natural Science Foundation of Fujian Province 2023J01568Startup Fund for Scientific Research of Fujian Medical University 2020QH1044
6 · The paper itself

Abstract

purposeTo compare the potential efficiency of [

methodsTwenty-five RCC patients confirmed by pathology were enrolled in this prospective study. The maximum standardized uptake value (SUV

results[

conclusion[

Indexed as

Carcinoma, Renal CellKidney NeoplasmsFluorodeoxyglucose F18Gallium RadioisotopesHumansIntegrinsOligopeptidesPositron Emission Tomography Computed TomographyProspective StudiesFluorodeoxyglucose F18Gallium RadioisotopesIntegrinsOligopeptides[68Ga]Ga-LNC1007Fibroblast activation proteinIntegrin αvβ3Renal cell carcinoma; [68Ga]Ga-PSMA

Identifiers

PMID37728667
OpenAlexW4386877602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.